June 8th is World Brain Tumor Day

June 8th is World Brain Tumor Day. American Brain Tumor Association explains a brain tumor as a growth of abnormal cells that form in the brain. These growths can be cancerous or benign. Often the first signs of brain tumors are headaches although many experience a wide variety of have symptoms such as vision loss, seizures, and dizziness. There are more than 100 distant types of brain tumors according to the National Brain Tumor Society. Gliomas are one of the most common in those with neurofibromatosis. Tumors are often categorized in stages or as low- or high-grade tumors. Low grade tumors are thought to be slow growing tumors and high-grade tumors are thought to be fast growing. Treatment also varies greatly depending on the type, size and location of the tumors Some common treatments include radiation therapy, chemotherapy, surgical removals or even just observation for changes. Each person and treatment are different. It is always best to follow your physician’s guidance and even get second opinions if needed.

In neurofibromatosis type 1 about 15% of NF1 patients develop brain tumors called gliomas, usually during childhood. The most common gliomas associated with NF1 are astrocytoma, brain stem glioma and optic pathway glioma.

People with NF2-related schwannomatosis often develop bilateral vestibular schwannomas, also known as acoustic neuromas in the brain. They may also develop Meningiomas, a slow-growing tumor that usually develops on the surface of the brain or gliomas, including ependymomas.

A FEW NF1 & NF2/SWN RESOURCES & ARTICLES

From NF Midwest’s 2021 iNFo Fair a recorded presentation on NF1 brain tumors by Dr. Virginia Harrod.

Children’s Hospital of Philadelphia Receives $10 Million Grant from the Gilbert Family Foundation to Accelerate Neurofibromatosis Research.

Drug Found To Stop Nervous System Tumor Growth [Note: This is in mice.]

NF Midwest Be iNFormed article on Brainstem Tumors in Neurofibromatosis Type 1 by Dr. Robert Listernick from 2018.

Recently published (Aug 2022) Systematic Review of Pediatric Brain Tumors in Neurofibromatosis Type 1: Status of Gene Therapy.

American Brain Tumor Association Support Groups

Recent Posts

  • Barriers to Healthcare Access and Psychosocial Experiences in Adults with Neurofibromatosis Type 1

    Offered by: University of Colorado AnschutzConducted by: Katelyn Glowinski, genetic counseling student, master’s program This research study is designed to gain a better understanding of healthcare barriers faced by adults with Neurofibromatosis Type 1 (NF1), as well as evaluate any associations between these barriers and your self-reported neuropsychiatric or mental health status. If you join... Read More
  • Where Belonging Can Lead: Rachel’s Journey with NF Midwest 

    Rachel was 13 when she first attended Camp NF.  At an age when so much was changing, camp gave her something she deeply needed: the chance to meet other young people who understood life with NF.  “NF camp gave me the opportunity to connect with others who had a shared experience and come to understand... Read More

Responses

Respond

Your email address will not be published. Required fields are marked *